There is still room for improvement to the National Rosacea Society Expert Committee's updated classification schema for rosacea, according to William James, M.D.
Stay up-to-date on the most recent clinical advances in atopic dermatitis.
Brett Coldiron, M.D., offers insight on how recent legislative and regulatory changes may impact your practice.
JAK inhibitors have shown efficacy across several conditions due to the number and role of cytokines in the pathogenesis of these conditions, one expert says.
Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments in her presentation at the Fall Clinical Dermatology Conference in Las Vegas.
For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.
The shift from antihistamines to newer drugs for treating pruritus is rapidly accelerating. Gil Yosipovitch, M.D. shares the treatments you should know in his presentation at the Fall Clinical Dermatology Conference in Las Vegas.
Changes in government medical billing and coding for dermatologists and other physicians is scheduled to begin January 2021.
In order for a dermatology practice to advance to the next financial level, it is important to identify needed areas of improvement. This is where benchmarking comes into play.
What is a life worth? Does it come down to dollars and cents? A recent study examines these questions in light of current and projected costs of melanoma treatment.